Sosei Group (JP:4565) has released an update.
Nxera Pharma Co., Ltd, formerly known as Sosei Group Corporation, reported a significant increase in revenue for the nine months ending September 30, 2024, with a 301.6% rise compared to the same period in 2023. Despite this growth, the company still faced a net loss of 3,503 million yen, although this is an improvement from the previous year’s loss. The company’s total assets slightly decreased, while equity increased, indicating a strengthening financial position.
For further insights into JP:4565 stock, check out TipRanks’ Stock Analysis page.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
